4.7 Review

Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction

期刊

NEUROPHARMACOLOGY
卷 177, 期 -, 页码 -

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2020.108256

关键词

-

资金

  1. National Institutes of Health (National Institute on Alcohol Abuse and Alcoholism) [R01 AA026267, UO1 AA025931]
  2. National Institutes of Health (National Institute of Neurological Disorders and Stroke) [R01 NS021229]
  3. National Institutes of Health (National Institute on Drug Abuse) [R01 DA044205, R01 DA049545]
  4. Hartwell Foundation
  5. Chernowitz Medical Research Foundation

向作者/读者索取更多资源

Nicotine is a highly addictive drug found in tobacco that drives its continued use despite the harmful consequences. The initiation of nicotine abuse involves the mesolimbic dopamine system, which contributes to the rewarding sensory stimuli and associative learning processes in the beginning stages of addiction. Nicotine binds to neuronal nicotinic acetylcholine receptors (nAChRs), which come in a diverse collection of subtypes. The nAChRs that contain the alpha 4 and beta 2 subunits, often in combination with the alpha 6 subunit, are particularly important for nicotine's ability to increase midbrain dopamine neuron firing rates and phasic burst firing. Chronic nicotine exposure results in numerous neuroadaptations, including the upregulation of particular nAChR subtypes associated with long-term desensitization of the receptors. When nicotine is no longer present, for example during attempts to quit smoking, a withdrawal syndrome develops. The expression of physical withdrawal symptoms depends mainly on the alpha 2, alpha 3, alpha 5, and beta 4 nicotinic subunits in the epithalamic habenular complex and its target regions. Thus, nicotine affects diverse neural systems and an array of nAChR subtypes to mediate the overall addiction process.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据